Identifying Temporal Changes to the Prescribing of Anti‐Arrhythmics for Atrial Fibrillation

E-ISSN： 2055-2335|40|4|285-289

ISSN： 1445-937x

Source： JOURNAL OF PHARMACY PRACTICE AND RESEARCH, Vol.40, Iss.4, 2010-12, pp. : 285-289

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Warfarin prescribing in atrial fibrillation (AF) was significantly improved with an educational programme

Inpharma, Vol. 1, Iss. 1470, 2005-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Utility of Anti-Arrhythmic Medications in ‘Lone Atrial Fibrillation’

Current Pharmaceutical Design, Vol. 21, Iss. 5, 2015-02 ,pp. : 573-579

Bentham Science Publishers

Access to resources Recommend Favorite

Developing New Anti-Arrhythmics: Clues from the Molecular Basis of Cardiac Ryanodine Receptor (RyR2) Ca2+-Release Channel Dysfunction

Current Pharmaceutical Design, Vol. 13, Iss. 31, 2007-11 ,pp. : 3195-3211

Bentham Science Publishers

Access to resources Recommend Favorite

New and old anti-thrombotic treatments for patients with atrial fibrillation

By Messori Andrea

International Journal of Clinical Pharmacy, Vol. 35, Iss. 3, 2013-06 ,pp. : 297-302

Springer Publishing Company

Access to resources Recommend Favorite

Dofetilide: a class III anti-arrhythmic drug for the treatment of atrial fibrillation

By Torp-Pedersen C. Brendorp B. Køber L.

Expert Opinion on Investigational Drugs, Vol. 9, Iss. 11, 2000-11 ,pp. : 2695-2704

Informa Healthcare

Access to resources Recommend Favorite